Regulus Therapeutics Inc. IPO Research Information

Regulus Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Regulus Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Regulus Therapeutics Inc.	RGLS -	$10.00-$12.00	$4.00	$4.73	11.25 million	9/7/2012
Underwriter(s): Lazard Capital Markets, Cowen and Company, BMO Capital Markets
Co-Manager(s): Needham & Co., Wedbush PacGrow Life Sciences
Industry: Health Care
Filing(s): Filed 2012-08-17

Regulus Therapeutics Inc. Quote & Chart - Click for current quote - RGLS

About Regulus Therapeutics Inc. (adapted from Regulus Therapeutics Inc. prospectus):
They are a biopharmaceutical company focused on discovering and developing first-in-class drugs that target microRNAs to treat a broad range of diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RGLS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.